Literature DB >> 12908998

Subclassification of preeclampsia.

Peter von Dadelszen1, Laura A Magee, James M Roberts.   

Abstract

Preeclampsia is a heterogeneous disorder, and as with other diseases (e.g., type I and type II diabetes), progress in the understanding of this disorder would be assisted greatly if subtypes could be characterized. We suggest that a first step would be to subdivide preeclampsia into early-onset disease (< 34 + 0 weeks') and late onset disease (> 34 + 0 weeks').

Entities:  

Mesh：

Year:  2003        PMID： 12908998     DOI： 10.1081/PRG-120021060

Source DB:  PubMed          Journal:  Hypertens Pregnancy        ISSN： 1064-1955            Impact factor:   2.108


  188 in total

Review 1.  Placental pathology: its impact on explaining prenatal and perinatal death.

Authors:  Thomas Stallmach; Gundula Hebisch
Journal:  Virchows Arch       Date:  2004-05-11       Impact factor: 4.064

Review 2.  Extracellular nucleic acids in maternal circulation as potential biomarkers for placental insufficiency.

Authors:  Ilona Hromadnikova
Journal:  DNA Cell Biol       Date:  2012-02-24       Impact factor: 3.311

3.  DNA methylation profiling of human placentas reveals promoter hypomethylation of multiple genes in early-onset preeclampsia.

Authors:  Ryan Kc Yuen; Maria S Peñaherrera; Peter von Dadelszen; Deborah E McFadden; Wendy P Robinson
Journal:  Eur J Hum Genet       Date:  2010-05-05       Impact factor: 4.246

4.  Molecular and vascular targets in the pathogenesis and management of the hypertension associated with preeclampsia.

Authors:  Ossama M Reslan; Raouf A Khalil
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2010-10-01

5.  Low placental growth factor across pregnancy identifies a subset of women with preterm preeclampsia: type 1 versus type 2 preeclampsia?

Authors:  Robert W Powers; James M Roberts; Daniel A Plymire; Dominick Pucci; Saul A Datwyler; Don M Laird; David C Sogin; Arun Jeyabalan; Carl A Hubel; Robin E Gandley
Journal:  Hypertension       Date:  2012-05-29       Impact factor: 10.190

Review 6.  Genetic, immune and vasoactive factors in the vascular dysfunction associated with hypertension in pregnancy.

Authors:  Sajjadh M J Ali; Raouf A Khalil
Journal:  Expert Opin Ther Targets       Date:  2015-08-17       Impact factor: 6.902

Review 7.  Disturbances in placental immunology: ready for therapeutic interventions?

Authors:  Sinuhe Hahn; Anurag Kumar Gupta; Carolyn Troeger; Corinne Rusterholz; Wolfgang Holzgreve
Journal:  Springer Semin Immunopathol       Date:  2006-04-26

8.  Maternal and Cord Blood Plasma sEng and TGF-β1 in Patients with Hypertensive Disorders of Pregnancy: A Pilot Study in a South Indian Population.

Authors:  Vickneshwaran Vinayagam; Zachariah Bobby; Syed Habeebullah; Latha Chaturvedula; Shruthi K Bharadwaj
Journal:  J Clin Diagn Res       Date:  2017-03-01

9.  Adenosine A2A receptor regulates expression of vascular endothelial growth factor in feto-placental endothelium from normal and late-onset pre-eclamptic pregnancies.

Authors:  Jesenia Acurio; Kurt Herlitz; Felipe Troncoso; Claudio Aguayo; Patricio Bertoglia; Carlos Escudero
Journal:  Purinergic Signal       Date:  2016-09-30       Impact factor: 3.765

10.  Role of IL-6 -174(G/C) promoter polymorphism in the etiology of early-onset preeclampsia.

Authors:  Sabnavis Sowmya; Aruna Ramaiah; Pratibha Nallari; Akka Jyothy; Ananthapur Venkateshwari
Journal:  Inflamm Res       Date:  2015-04-28       Impact factor: 4.575
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.